VKTX
VKTX
NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$25.80
-2.17 (-7.76%)
As of Nov 5, 8:35 PM ET ·
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 23 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +164.4% upside
Low Target $46.84
Average Target $68.21
High Target $80.11
Current Price $25.80
Current
$25.80
Target
$68.21
$46.84 $68.21 avg $80.11
Scenario Analysis
Bear Case
$46.84
81.6%
Low target
Base Case
$68.21
+164.4%
Avg target
Bull Case
$80.11
+210.5%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$43.15
-40.2% from high
52-Week Low
$23.82
+8.3% from low
50-Day SMA
$30.10
-14.3% vs SMA
200-Day SMA
$32.31
-20.1% vs SMA
RSI (14)
52.4
Neutral
Target vs 52W High
$68.21
+58.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%